Genelux Says Frontiers In Oncology Published Case Report Of Platinum-Relapsed Small Cell Lung Cancer Patient Achieving 16.7 Months Progression-Free Survival And 84.6% Target Lesion Reduction After Olvi-Vec And Platinum Rechallenge

뉴스 본문을 불러오고 있어요.

Genelux Says Frontiers In Oncology Published Case Report Of Platinum-Relapsed Small Cell Lung Cancer Patient Achieving 16.7 Months Progression-Free Survival And 84.6% Target Lesion Reduction After Olvi-Vec And Platinum Rechallenge | 웨이프 WAPE

Genelux Says Frontiers In Oncology Published Case Report Of Platinum-Relapsed Small Cell Lung Cancer Patient Achieving 16.7 Months Progression-Free Survival And 84.6% Target Lesion Reduction After Olvi-Vec And Platinum Rechallenge

기사 요약

관련 종목

댓글 —